RecruitingNCT02497534

Biomarkers in Friedreich's Ataxia


Sponsor

University of Florida

Enrollment

203 participants

Start Date

Sep 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this project is to characterize measures of cardiac performance and neuromuscular physiology in FA patients using novel techniques, including echocardiography and magnetic resonance imaging (MRI), metabolic exercise testing, and neurophysiological outcomes.


Eligibility

Min Age: 6 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with friedreich's ataxia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Florida

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02497534


Related Trials